A new Colorado law is set to alter the way pharmacy benefit managers are paid, making it one of the most aggressive efforts to date in a nationwide push to overhaul the industry’s business practices.
Critics of the industry have long argued that pharmacy benefit managers’ obscure and complex business models have inflated the price of prescription drugs, largely through rebates that they negotiate with drug companies and fees they collect from insurers.
Already a subscriber? Sign in